Company Filing History:
Years Active: 1988
Title: Yoshiaki Ogasawara: Innovator in Anti-Asthmatic Solutions
Introduction
Yoshiaki Ogasawara is a notable inventor based in Odawara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-asthmatic agents. His innovative work has led to the creation of a unique composition that addresses the needs of asthma patients.
Latest Patents
Ogasawara holds a patent for an anti-asthmatic composition and the process for preparing it. The patent, titled "5-(3-n-Butyloxalylaminophenyl) tetrazole," demonstrates an excellent SRS-A release-inhibiting effect. This compound serves as an effective component for an anti-asthmatic agent. The pharmaceutical preparation, which involves mixing the tetrazole with a specific dispersant such as polysorbate-80 in the presence of a non-aqueous solvent, exhibits high solubility and bioavailability.
Career Highlights
Yoshiaki Ogasawara is associated with Wakamoto Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in respiratory therapies. His work has not only contributed to the scientific community but has also provided practical solutions for patients suffering from asthma.
Collaborations
Ogasawara has collaborated with notable colleagues, including Tooru Abe and Yukiyoshi Yanagihara. These partnerships have fostered a collaborative environment that enhances innovation and the development of effective pharmaceutical solutions.
Conclusion
Yoshiaki Ogasawara's contributions to the field of anti-asthmatic agents highlight his dedication to improving patient care through innovative solutions. His patent and ongoing work at Wakamoto Pharmaceutical Co., Ltd. underscore the importance of research in developing effective treatments for respiratory conditions.